Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

Optimised Connectivity is Fundamental to Integrity & Safety of Hygienic Processing

Every product for consumption, ingestion, injection, or cosmetic use must be safe for use and be in perfect condition when used. Micro- organisms, toxic substances and any other contaminants that could impair quality or introduce risk are not permitted. Marc Klingler at Bürkert discusses these dangers and how a hygienic processing production plant has to ensure that all necessary measures are taken to be certain that public safety and wellbeing are preserved.

https://international-pharma.com/wp-content/uploads/2013/04/1-Optimised-Connectivity-is-Fundamental-to-Integrity-Safety-of-Hygienic-Processing.pdf
Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025